Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombocythemia, Essential”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03566446
What this trial is testing

CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm, UnclassifiableEssential ThrombocythemiaMyelofibrosis
Inge Marie Svane 10
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00002504
What this trial is testing

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Hoag Memorial Hospital Presbyterian
Large-scale testing (Phase 3)Study completedNCT01969838
What this trial is testing

Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-Polycythemia Vera MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis
Sierra Oncology LLC - a GSK company 432
Not applicableNot Yet RecruitingNCT07645755
What this trial is testing

CRETA (Clopidogrel Responsiveness in Essential ThrombocithemiA)

Who this might be right for
Essential Thrombocythemia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Not applicableUnknownNCT02897297
What this trial is testing

Myeloproliferative Neoplastic Diseases Observatory From Brest

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaPrimary Myelofibrosis
University Hospital, Brest 1,000
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Not applicableLooking for participantsNCT07590986
What this trial is testing

Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm

Who this might be right for
Myeloproliferative Neoplasm (MPN)Polycytemia VeraEssential Thrombocythemia (ET)+1 more
Université Catholique de Louvain 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05481151
What this trial is testing

Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

Who this might be right for
Polycythemia Vera
PharmaEssentia 111
Large-scale testing (Phase 3)Study completedNCT04173494
What this trial is testing

Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Sierra Oncology LLC - a GSK company 195
Testing effectiveness (Phase 2)Ended earlyNCT01790295
What this trial is testing

Ruxolitinib Prior to Transplant in Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost Polycythemia Vera MyelofibrosisPost Essential Thrombocythemia Myelofibrosis
John Mascarenhas 21
Not applicableStudy completedNCT03212053
What this trial is testing

Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET)

Who this might be right for
Thrombocythemia Essential
Hospices Civils de Lyon 51
Testing effectiveness (Phase 2)Study completedNCT03194542
What this trial is testing

A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence

Who this might be right for
Primary MyelofibrosisAnemia
Celgene 95
Large-scale testing (Phase 3)Study completedNCT01230775
What this trial is testing

Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia

Who this might be right for
Essential Thrombocythaemia
AOP Orphan Pharmaceuticals AG 146
Not applicableUnknownNCT05883904
What this trial is testing

Real World Evidence of Fedratinib Effectiveness in MF

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Gruppo Italiano Malattie EMatologiche dell'Adulto 93
Not applicableLooking for participantsNCT06734637
What this trial is testing

Efficacy and Safety of Peginterferon in ET and PV.

Who this might be right for
Essential ThrombocythemiaPolycythemia Vera
Zhenya Hong 40
Testing effectiveness (Phase 2)Study completedNCT02742324
What this trial is testing

Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg

Who this might be right for
Myelofibrosis
French Innovative Leukemia Organisation 37
Not applicableLooking for participantsNCT02760238
What this trial is testing

Myeloproliferative Neoplasms (MPNs) Patient Registry

Who this might be right for
Primary MyelofibrosisPolycythemia VeraEssential Thrombocythemia+7 more
University Health Network, Toronto 5,000
Post-approval studies (Phase 4)Study completedNCT03232177
What this trial is testing

Anagre Cap. in Patients With High-Risk Essential Thrombocythemia

Who this might be right for
Essential Thrombocythemia
Yuhan Corporation 70
Next Page